Igene Biotechnology, Inc.
IGNE
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Net Income | 22.68% | -47.76% | -42.08% | -436.59% | 120.28% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 35.12% | -31.15% | -1.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -142.87% | -15.31% | 125.60% | -256.39% | 387.24% |
| Change in Net Operating Assets | -26.16% | 1,166.67% | -99.68% | 261.46% | -166.36% |
| Cash from Operations | -145.20% | -2,181.89% | 98.10% | -265.64% | -23.43% |
| Capital Expenditure | 100.00% | -- | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 231.58% | 70.31% | -134.22% | 314.94% | -116.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.98% | -1,472.63% | 96.97% | -258.45% | -32.87% |